NCT05137106

Brief Summary

The aim of the study is to evaluate the effects of active dry needling (aDN) in the treatment of myofascial trigger points of the infraspinatus muscle (MTP). For this purpose, this technique was compared to placebo dry needling (pDN) for short-term pain relief and increased glenohumeral internal rotation range. The second objective is to explore whether improvements in perceived pain and functional capacity correlate with changes in electromyographic activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 30, 2021

Completed
Last Updated

November 30, 2021

Status Verified

November 1, 2021

Enrollment Period

2.4 years

First QC Date

November 10, 2021

Last Update Submit

November 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Pain intensity

    The Visual Analogue Scale (VAS) was used to assess pain intensity. This scale consists of a sequence of numbers from 0 to 10, in which 0 represents "no pain" and 10 represents "worst pain imaginable".

    At baseline, immediately after the intervention, 72 hours after the intervention

Secondary Outcomes (3)

  • Change in Pressure Pain Threshold

    At baseline, immediately after the intervention, 72 hours after the intervention

  • Changes in Range of motion

    At baseline, immediately after the intervention, 72 hours after the intervention

  • Changes in EMG activity

    At baseline, immediately after the intervention, 72 hours after the intervention

Study Arms (2)

Active Dry Needling

EXPERIMENTAL

Active dry needling (ADN). Intramuscular insertion Intervention/treatment. All participants in this group received an ADN session with an intramuscular insertion of a 25 mm X 0.22 mm JEMCO acupuncture needle into the infraspinatus muscle. The dry needling was performed with the rapid entry and exit technique.

Other: Active Dry Needling

Sham Dry needling

SHAM COMPARATOR

Sham dry needling (SDN). All participants in this group received one session of SDN with a 25 mm X 0.22 mm JEMCO acupuncture needle over the infraspinatus region. To ensure that the blunt needles did not puncture the skin during the experimental session (and for patient comfort), each needle was individually cut and polished and checked for sharpness against the investigator's fingertip. As a precaution against infection, each patient was treated with a separate dummy needle.

Other: Sham Dry needling

Interventions

All participants in this group received an ADN session with an intramuscular insertion of a 25 mm X 0.22 mm acupuncture needle into the infraspinatus muscle. The dry needling was performed with the rapid entry and exit technique.

Active Dry Needling

All participants in this group received one session of SDN with a 25 mm X 0.22 mm acupuncture needle over the infraspinatus region. To ensure that the blunt needles did not puncture the skin during the experimental session (and for patient comfort), each needle was individually cut and polished and checked for sharpness against the investigator's fingertip. As a precaution against infection, each patient was treated with a separate dummy needle.

Sham Dry needling

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Subjects with unilateral shoulder pain
  • Glenohumeral internal rotation deficit
  • Presence of active myofascial trigger point in the infraspinatus muscle

You may not qualify if:

  • Previous surgery in the upper limb
  • Previous physiotherapy treatments in the shoulder
  • Dry needling contraindications
  • Previous dry needling experience to mantain the blinding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Gran Rosario

Rosario, Santa Fe Province, 2000, Argentina

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double (Participants and Outcomes Assessor)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Active Dry Needling Sham Dry Needling
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the University Center for Assistance, Teaching and Research

Study Record Dates

First Submitted

November 10, 2021

First Posted

November 30, 2021

Study Start

October 1, 2018

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

November 30, 2021

Record last verified: 2021-11

Locations